Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Looking for value? Find out what credit card has the best rewards and no annual fee to maximize your financial benefits without added costs.
28,655 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Bitcoin briefly topped $80,000 again as traders weigh whether the move signals real demand or a looming reversal. Ana...
Bitcoin fell to the $75,000 area after a volatile week of gains and selling. On-chain flows, high-profile bets, and F...
Investors ditching magnificent group are chasing a fresh AI-led cohort dubbed MANGOS, with Meta, Alphabet and NVIDIA ...
ADA neared a multi-year trough as markets digested a broad crypto selloff. Analysts warn gains may come, but a cardan...
Singapore’s MAS placed Hyperliquid on the Investor Alert List, signaling a public notice rather than an enforcement a...
The yen is on a renewed slide, with policymakers juggling debt, inflation, and global rate moves as quietly crashing ...
The Nasdaq 100 ETF is seeing its busiest month in years as traders chase SpaceX exposure, aided by new weighting rule...
IBM’s market collapse is forcing a reckoning on its future strategy as Microsoft and Apple deepen AI and cloud leader...
Britain pre-positions HMS Dragon in the Middle East as part of plans for a Europe-led mission to escort ships through...
U.S. equities extended gains as investors digested a leadership shift at the Federal Reserve and a cautious path for ...
Hungary blocks a massive EU loan to Ukraine, tying funding to the restart of Druzhba pipeline oil flows after a disru...